John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 197,500 shares at $244.45 ($48.2M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Seasonal sale ($48.2M) by Chief Executive Officer — this insider has traded BGNE in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $240.53 | 5,956 | $1.4M | 3.0% |
| 2 | $240.53 | 5,956 | $1.4M | 3.0% |
| 3 | $241.38 | 13,816 | $3.3M | 6.9% |
| 4 | $241.38 | 13,816 | $3.3M | 6.9% |
| 5 | $242.46 | 8,192 | $2.0M | 4.1% |
| 6 | $242.46 | 8,192 |
| $2.0M |
| 4.1% |
| 7 | $243.44 | 11,195 | $2.7M | 5.7% |
| 8 | $243.44 | 11,195 | $2.7M | 5.7% |
| 9 | $244.45 | 4,910 | $1.2M | 2.5% |
| 10 | $244.45 | 4,910 | $1.2M | 2.5% |
| 11 | $244.56 | 18,386 | $4.5M | 9.3% |
| 12 | $244.56 | 18,386 | $4.5M | 9.3% |
| 13 | $245.36 | 1,090 | $267K | 0.6% |
| 14 | $245.36 | 1,090 | $267K | 0.6% |
| 15 | $245.51 | 19,232 | $4.7M | 9.8% |
| 16 | $245.51 | 19,232 | $4.7M | 9.8% |
| 17 | $246.57 | 7,243 | $1.8M | 3.7% |
| 18 | $246.57 | 7,243 | $1.8M | 3.7% |
| 19 | $247.63 | 6,480 | $1.6M | 3.3% |
| 20 | $247.63 | 6,480 | $1.6M | 3.3% |
| 21 | $248.63 | 3,900 | $970K | 2.0% |
| 22 | $249.25 | 600 | $150K | 0.3% |
| Total | $244.20 avg | 197,500 | $48.2M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |